Aurinia Pharmaceuticals Stock Technical Analysis
| AUPH Stock | USD 7.95 0.05 0.62% |
As of the 1st of February, Aurinia Pharmaceuticals shows the Downside Deviation of 2.24, mean deviation of 2.19, and Risk Adjusted Performance of 0.0712. Aurinia Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Aurinia Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Aurinia, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AuriniaAurinia |
Aurinia Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 10.84 | Strong Buy | 7 | Odds |
Most Aurinia analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aurinia stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aurinia Pharmaceuticals, talking to its executives and customers, or listening to Aurinia conference calls.
Aurinia Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Aurinia Pharmaceuticals Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Aurinia Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Aurinia Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Aurinia Pharmaceuticals. You can use it to identify possible trend reversals for Aurinia Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Aurinia Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Aurinia Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Aurinia Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.0049 , which may suggest that Aurinia Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.9, which is the sum of squared deviations for the predicted Aurinia Pharmaceuticals price change compared to its average price change.About Aurinia Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Aurinia Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Aurinia Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Aurinia Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Aurinia Pharmaceuticals. By analyzing Aurinia Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Aurinia Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Aurinia Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 1.83 | 3.27 | 2.94 | 2.2 | Days Of Inventory On Hand | 1.6K | 1.0K | 921.9 | 510.62 |
Aurinia Pharmaceuticals February 1, 2025 Technical Indicators
Most technical analysis of Aurinia help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aurinia from various momentum indicators to cycle indicators. When you analyze Aurinia charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0712 | |||
| Market Risk Adjusted Performance | 0.6228 | |||
| Mean Deviation | 2.19 | |||
| Semi Deviation | 2.03 | |||
| Downside Deviation | 2.24 | |||
| Coefficient Of Variation | 1308.99 | |||
| Standard Deviation | 3.15 | |||
| Variance | 9.95 | |||
| Information Ratio | 0.0447 | |||
| Jensen Alpha | 0.1971 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0629 | |||
| Treynor Ratio | 0.6128 | |||
| Maximum Drawdown | 19.06 | |||
| Value At Risk | (3.50) | |||
| Potential Upside | 3.88 | |||
| Downside Variance | 5.04 | |||
| Semi Variance | 4.13 | |||
| Expected Short fall | (2.73) | |||
| Skewness | 1.95 | |||
| Kurtosis | 6.58 |
Complementary Tools for Aurinia Stock analysis
When running Aurinia Pharmaceuticals' price analysis, check to measure Aurinia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurinia Pharmaceuticals is operating at the current time. Most of Aurinia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aurinia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurinia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aurinia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |